APOE and hypertensive disorder: This finding raises questions about galantamine’s efficacy, potentially due to differences in patient characteristics, such as gender (p = 0.04), and clinical factors like hypertension and ADAS-Cog scores, which were significantly different between APOE carriers and non-carriers.